Tag: FDA

COVID-19 Autumn Policy Roundup
As 2021 ends, the COVID-19 virus is still infecting thousands of people in the country each day. Although the summer provided a brief respite from the virus—with case counts dropping ...

Analyzing the Effects of Public Health Messaging on Vaccine Hesitancy
Introduction To date, the COVID-19 vaccination effort has been largely successful for the United States; however, vaccine hesitancy is a major factor preventing the nation from reaching herd immunity. The ...

Update on Vermont’s Efforts to Implement Wholesale Importation of Prescription Drugs from Canada
The COVID-19 pandemic has impacted many state policy efforts over the last year, with state agencies across the U.S. re-deploying their staff towards tracing and vaccination work. This has undoubtedly contributed to less momentum on drug importation efforts at the state ...

How States Can Improve COVID-19 Vaccine Distribution
The COVID-19 pandemic has been the greatest public health crisis of our lifetime—but fortunately, it has been met with a scientific response equally as strong. Multiple vaccines were created, tested, ...

NAMD Conference Offers Reflection on 2020, Contemplation of Health Policy in 2021
Members of PCG’s Health team attended the National Association of Medicaid Directors (NAMD) virtual conference from November 9th – November 11th. The conference breakout sessions showcased Medicaid Directors sharing various ...

Health Policy Updates: COVID-19 and Beyond
As summer came to a close, health policy developments continued at the federal level. Below, we provide brief overviews of updates both related and unrelated to the COVID-19 pandemic, along ...

House passes 21st Century Cures bill
On November 30, 2016, the U.S. House of Representatives passed an amended “21st Century Cures” bill by a 392-26 vote. The bill covers a diverse range of topics, such as: ...